Bidirectional Regulation of Opioid and Chemokine Function
Open Access
- 31 January 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 94
Abstract
The opioid family of GPCRs consists of the classical opioid receptors, designated μ-, κ-, and δ-opioid receptors, and the orphanin-FQ receptor, and these proteins are expressed on both neuronal and hematopoietic cells. A number of laboratories have reported that an important degree of cross-talk can occur between the opioid receptors and the chemokine and chemokine receptor families. As a part of this, the opioid receptors are known to regulate the expression of certain chemokines and chemokine receptors, including those that possess strong pro-inflammatory activity. At the level of receptor function, it is clear that certain members of the chemokine family can mediate cross-desensitization of the opioid receptors. Conversely, the opioid receptors are all able to induce heterologous desensitization of some of the chemokine receptors. Consequently, activation of one or more of the opioid receptors can selectively cross-desensitize chemokine receptors and regulate chemokine function. These cross-talk processes have significant implications for the inflammatory response, since the regulation of both the recruitment of inflammatory cells, as well as the sensation of pain, can be controlled in this way.Keywords
Funding Information
- National Institutes of Health
This publication has 140 references indexed in Scilit:
- Protein Kinase Cζ Mediates μ-Opioid Receptor-induced Cross-desensitization of Chemokine Receptor CCR5Journal of Biological Chemistry, 2011
- Disruption of neuronal CXCR4 function by opioids: Preliminary evidence of Ferritin Heavy Chain as a potential etiological agent in neuroAIDSJournal of Neuroimmunology, 2010
- Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the κ-opioid receptorJournal of Neuroimmunology, 2008
- GTPγS Incorporation in the Rat Brain: A Study on μ-Opioid Receptors and CXCR4Journal of Neuroimmune Pharmacology, 2007
- Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin releaseBiochemical Pharmacology, 2007
- The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of ratsBrain Research, 2007
- Janus kinase 3‐deficient T lymphocytes have an intrinsic defect in CCR7‐mediated homing to peripheral lymphoid organsImmunology, 2007
- Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in ratsDrug and Alcohol Dependence, 2006
- Nuclear Factor κB Signaling in Opioid Functions and Receptor Gene ExpressionJournal of Neuroimmune Pharmacology, 2006
- Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGOJournal of NeuroVirology, 2006